Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
spinal cord stimulation
MedTech
Globus Medical to buy neurostim developer Nevro for $250M
With Globus paying $5.85 for each of Nevro’s outstanding shares, that amounts to a 27% premium over a 90-day weighted average.
Conor Hale
Feb 10, 2025 10:51am
FDA approves Medtronic’s closed-loop spinal cord stimulator
Apr 26, 2024 11:31am
FDA expands OK for Boston Sci WaveWriter spinal cord stimulators
Feb 6, 2024 12:28pm
Medtronic touts study success for new spinal cord stimulators
Jan 19, 2024 12:00pm
Spinal cord stimulators boost balance in foot amputees: study
Dec 15, 2023 1:35pm
Boston Sci spinal cord stimulators nab diabetic neuropathy nod
Oct 12, 2023 10:44am
